Publication | Open Access

Radiation Therapy Oncology Group 0247: A Randomized Phase II Study of Neoadjuvant Capecitabine and Irinotecan or Capecitabine and Oxaliplatin With Concurrent Radiotherapy for Patients With Locally Advanced Rectal Cancer

Radiation MedicineRadiation TherapyMedicineConcurrent RadiotherapyNeoadjuvant CapecitabineClinical Radiation OncologyOncologyRadiation OncologyRadiologyHealth Sciences